Eupry Revenue and Competitors
Employee Data
- Eupry has 71 Employees.
- Eupry grew their employee count by -3% last year.
Eupry's People
Name | Title | Email/Phone |
---|---|---|
1 | Cofounder and head quality | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief electronic hardware developer | Reveal Email/Phone |
4 | CMO | Reveal Email/Phone |
5 | Revenue Operations Manager | Reveal Email/Phone |
6 | Production & Office Assistant | Reveal Email/Phone |
Eupry Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 148 | 9% | N/A | N/A |
#2 | N/A | 71 | -7% | N/A | N/A |
#3 | $7.5M | 270 | 10% | N/A | N/A |
#4 | N/A | 82 | -22% | N/A | N/A |
#5 | N/A | 411 | 14% | N/A | N/A |
#6 | N/A | 71 | -3% | N/A | N/A |
#7 | N/A | 1463 | 5% | N/A | N/A |
What Is Eupry?
Eupry supports further development of host of industries including Laboratory, Pharmacy, Healthcare, Pharma, Food and more by providing efficient solutions to monitor temperature sensitive assets. Traditional approaches in terms of temperature monitoring are demanding and require many resources that prevent companies from re-investing their funds into achieving higher results. At Eupry, we take this responsibility by delivering an innovative Temperature Monitoring Service that removes almost all of the time organisations currently spend on temperature monitoring. Our services ensure compliance to your quality standards and include yearly 3-Point traceable calibration or ISO17025 Accredited calibration, FDA Part 11 compliance, GxP compliance and more. Eupry can save up to 30 hours a year per monitoring point, time which in every circumstance, would be better spent elsewhere in the organisation.
keywords:N/AN/A
Total Funding
71
Number of Employees
N/A
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 71 | 65% | N/A |
#2 | $9.1M | 72 | 24% | N/A |
#3 | $9.4M | 72 | 1% | N/A |
#4 | $16.5M | 73 | 18% | N/A |
#5 | $9.5M | 73 | 26% | N/A |